ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 274 filers reported holding ARRAY BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $222,000 | -21.8% | 15,564 | -16.8% | 0.30% | +12.8% |
| Q3 2018 | $284,000 | -9.6% | 18,713 | 0.0% | 0.27% | -7.6% |
| Q2 2018 | $314,000 | -0.9% | 18,713 | -3.7% | 0.29% | -13.3% |
| Q1 2018 | $317,000 | -15.7% | 19,429 | -33.8% | 0.33% | -13.5% |
| Q4 2017 | $376,000 | +161.1% | 29,367 | +151.3% | 0.38% | +118.2% |
| Q3 2017 | $144,000 | – | 11,686 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MUFG Americas Holdings Corp | 36,200 | $71,000 | 0.00% |